Capitol Account

Share this post

Two-Tier Market? Biotech Group Warns SEC's Trading Revamp Is Bad for Small Companies

www.capitolaccountdc.com

Two-Tier Market? Biotech Group Warns SEC's Trading Revamp Is Bad for Small Companies

Also, lawmaker drops bill to protect brokers from MiFID II; ICI amps up attacks on 'swing pricing'

Apr 13, 2023
∙ Paid
1
Share this post

Two-Tier Market? Biotech Group Warns SEC's Trading Revamp Is Bad for Small Companies

www.capitolaccountdc.com
Share

Lawmakers and business executives often point to the huge drop in the number of initial public offerings as evidence that government red tape has made it difficult for small businesses to raise money, grow and innovate. Now, a trade association representing biotech firms is warning that the regulatory headwinds could get even worse for startups. The cul…

Keep reading with a 7-day free trial

Subscribe to

Capitol Account
to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2023 Capitol Account
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing